How to decide who to treat

Best Practice & Research. Clinical Rheumatology
John A KanisAnders Oden

Abstract

Fractures are the clinical consequence of osteoporosis and are a major cause of morbidity and mortality worldwide. Although treatments are available that have been shown to decrease the risk of fracture, problems arise in identifying individuals at high risk of fracture so that intervention can be effectively targeted. Practice guidelines, available in many countries, differ markedly in approach, but generally recommend treatments on the basis of a previous fragility fracture and a defined threshold for bone mineral density (BMD). Recent developments in fracture risk assessment include the availability of the FRAX tool by the World Health Organization (WHO) Collaborating Centre for Metabolic Bone Diseases at Sheffield, UK, that integrates the weight of clinical risk factors for fracture risk with or without information on BMD and computes the 10-year probability of fracture. The tool increases sensitivity without trading specificity and is now being used in the re-appraisal of clinical guidelines.

References

Aug 27, 1992·The New England Journal of Medicine·B L Riggs, L J Melton
Jun 1, 1986·Annals of Internal Medicine·S R Cummings, D Black
Jun 1, 1986·Annals of Internal Medicine·S Ott
Nov 1, 1994·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A Kanis
Feb 27, 1995·The American Journal of Medicine·D M Black
Jul 1, 1997·International Journal of Technology Assessment in Health Care·D A MarshallE Jonsson
Jan 1, 1997·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisD Torgerson
Dec 16, 1998·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·A C LookerR Lindsay
Jul 11, 2001·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisB Jonsson
Nov 22, 2001·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·A N TostesonJ D Adachi
Jun 22, 2002·Lancet·Pierre D Delmas
Jul 12, 2002·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisUNKNOWN National Osteoporosis Foundation
Sep 17, 2002·Annals of Internal Medicine·UNKNOWN U.S. Preventive Services Task Force
Oct 16, 2002·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A Kanis, B Jonsson
Apr 23, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·John A KanisBengt Jönsson
May 26, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Angela M CheungUNKNOWN Canadian Task Force on Preventive Health Care
Sep 16, 2004·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Hans-Georg EichlerBengt Jönsson
Dec 25, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A Kanis, O Johnell
Jan 25, 2005·Bone·John A KanisBengt Jönsson
Feb 24, 2005·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Steven BoonenJean-Yves Reginster
Feb 27, 2007·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisN Yoshimura
May 9, 2007·Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry·Kerry SiminoskiJacques P Brown
Feb 23, 2008·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·B Dawson-HughesUNKNOWN National Osteoporosis Foundation Guide Committee
Feb 23, 2008·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S FujiwaraJ A Kanis
Feb 23, 2008·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisE McCloskey
Nov 1, 2008·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·K LippunerR Rizzoli
Jan 13, 2009·Maturitas·J CompstonUNKNOWN National Osteoporosis Guideline Group (NOGG)
Mar 28, 2009·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S W Y TsangA Oden

❮ Previous
Next ❯

Citations

Nov 2, 2012·Clinical Rheumatology·Bérengère Aubry-RozierDidier Hans
Feb 15, 2012·The Journal of Spinal Cord Medicine·Humberto MarreirosEulalia Calado
Aug 13, 2015·Multiple Sclerosis and Related Disorders·Bengt SkoogOluf Andersen
Nov 26, 2010·Maturitas·Mark BrincatUNKNOWN EMAS
Aug 12, 2015·Archives of Osteoporosis·Emma JonssonOskar Ström
Aug 7, 2012·Journal of Cachexia, Sarcopenia and Muscle·Matteo CesariUNKNOWN International Working Group on Sarcopenia
Mar 7, 2015·Current Osteoporosis Reports·Sophie A Jamal, Thomas L Nickolas
Jan 8, 2010·Maturitas·Tineke A C M van GeelPiet P Geusens
Feb 8, 2014·Transplantation·Kyla L NaylorAmit X Garg
Feb 3, 2015·The Journal of Rheumatology·Shirley L ChowUNKNOWN Canadian Rheumatology Association Choosing Wisely Committee
Feb 26, 2013·Orvosi hetilap·Zsolt DubravcsikAttila Szepes
Jan 29, 2019·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Etienne J BissonWilliam D Leslie
Feb 7, 2015·Clinical Journal of the American Society of Nephrology : CJASN·Kyla L NaylorSophie A Jamal
Jun 8, 2015·Current Opinion in Nephrology and Hypertension·Patrícia T GoldensteinRosa M A Moysés

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Human Reproduction Update
ESHRE Capri Workshop Group
American Journal of Preventive Medicine
Lionel S LimACPM Prevention Practice Committee
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Mickaël HiligsmannJean-Yves Reginster
© 2022 Meta ULC. All rights reserved